76379-02-7 Usage
General Description
BOC-D-GLU(OME)-OH is a chemical compound often used in peptide synthesis. It is a derivative of glutamic acid, an amino acid essential for protein synthesis and neurological function. The BOC (tert-butyloxycarbonyl) group is a protective group commonly used in peptide synthesis to prevent unwanted reactions at specific functional groups on the amino acid. The (OME) group indicates that a methoxy group is attached to the glutamic acid. Overall, BOC-D-GLU(OME)-OH is a key building block for creating peptides with specific sequence and structural properties, making it valuable in both biological and pharmaceutical research.
Check Digit Verification of cas no
The CAS Registry Mumber 76379-02-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,6,3,7 and 9 respectively; the second part has 2 digits, 0 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 76379-02:
(7*7)+(6*6)+(5*3)+(4*7)+(3*9)+(2*0)+(1*2)=157
157 % 10 = 7
So 76379-02-7 is a valid CAS Registry Number.
InChI:1S/C12H23N.C11H19NO6/c1-3-7-11(8-4-1)13-12-9-5-2-6-10-12;1-11(2,3)18-10(16)12-7(9(14)15)5-6-8(13)17-4/h11-13H,1-10H2;7H,5-6H2,1-4H3,(H,12,16)(H,14,15)/t;7-/m.0/s1
76379-02-7Relevant articles and documents
Glucosamine peptide derivatives, their production and use
-
, (2008/06/13)
Novel glucosamine-peptide derivatives of the formula: STR1 wherein m is 0 or 1; n is 0 or an integer of 1 to 9; R is lower alkyl which may be substituted with hydroxyl, or aryl; R1 is hydrogen or acyl having an acyclic hydrocarbon group, the terminal of which may be substituted with a cyclic hydrocarbon group directly, via a carbonyl group or via an oxygen atom; provided that when R1 is hydrogen m is 1; R2 is hydrogen or lower alkyl which may form a ring by connecting its terminal with the α-nitrogen atom when n is 0, or hydrogen when n is an integer of 1 to 9; R3 is hydrogen or lower alkyl; R4 and R5 are each hydrogen or lower alkyl which may be substituted with hydroxyl or benzyloxyl; R6 is hydrogen or lower alkyl; R7 is alkyl which may be substituted with lower alkoxyl or aralkyl; R8 and R9 are each hydrogen, lower alkyl or aralkyl; and (D) and (L) each indicate configurations if their respective carbon atoms are asymmetric; or an acid addition salt thereof, have immunostimulatory activity.